-
Professor Zhou Caicun: 2022 important clinical research in the field of lung cancer
Time of Update: 2023-02-02
NEJM Medical Frontiers invited Professor Zhou Caicun from the Department of Oncology, Shanghai Pulmonary Hospital affiliated to Tongji University, to review important advances in the field of lung cancer in 2022, including perioperative treatment of NSCLC, and targeted therapy and immunotherapy progress of advanced NSCLC.
-
"Lancet" heavyweight: lose 9 kg in 12 weeks, and also reduce sugar! The new triple agonist has a remarkable effect
Time of Update: 2023-01-06
👇 Click here to fill out the questionnaire and complete 👇 it in 1 minute▎WuXi AppTec content team editorThe use of multi-receptor agonists to treat hyperglycaemia and obesity in people with type 2 diabetes may improve short- and long-term outcomes.
-
"Lancet" heavyweight: lose 9 kg in 12 weeks, and also reduce sugar! The new triple agonist has a remarkable effect
Time of Update: 2023-01-06
👇 Click here to fill out the questionnaire and complete 👇 it in 1 minute▎WuXi AppTec content team editorThe use of multi-receptor agonists to treat hyperglycaemia and obesity in people with type 2 diabetes may improve short- and long-term outcomes.
-
【CSCO 2022 Prospect】IMpower010 research leads the reform of adjuvant therapy for early-stage non-small cell lung cancer
Time of Update: 2022-10-31
Lung cancer is one of the most life-threatening malignancies in a population. In recent years, the incidence of lung cancer has shown signs of increasing significantly in most countries, with non-smal
-
Case | penalty for the energy indicated on the product label that does not match the actual situation
Time of Update: 2022-09-14
Administrative Punishment Decision Document Number: Shanghai Supervision Pu Bureau Zi (2019) No. 152018012111Case Name: (Food and Medicine) A food company in Shanghai is suspected of producing food wi
-
Efficacy and mechanism of Nutrients sweet tea in preventing ulcerative colitis in mice
Time of Update: 2022-08-15
Figure 2 Potential mechanism of sweet tea extract alleviating DSS-induced UC via gut microbiota and its metabolites02Results and OutlookThe study found that sweet tea ethanol extract (the main components are trilobatin, phlorizin, phloretin and isoquercetin) significantly improved DSS-induced increase in disease activity index, weight loss, colon length shortening and colon pathology in UC mice damage .
-
[Crisis Management] Sudden bronchospasm during perianaesthesia
Time of Update: 2022-06-01
The main clinical manifestations of bronchospasm are bronchial smooth muscle spasmodic contraction, airway narrowing, sudden increase in ventilation resistance, expiratory dyspnea, causing hypoxia and carbon dioxide accumulation; wheezing sounds in the lungs, or disappearance of breath sounds on auscultation: Airway Resistance and peak pressure increased; oxygen saturation decreased continuously; PaO2 decreased and PETCO2 increased .
-
Vonolasheng is approved for maintenance treatment of reflux esophagitis, which significantly reduces the risk of recurrence
Time of Update: 2021-11-04
Studies have shown [2] that if there is no maintenance treatment after the initial treatment of RE patients, the mucosal recurrence rate is 70% at 6 months, and the mucosal recurrence rate is as high as 90% after 1 year, suggesting that RE is a chronic progressive disease and requires "initial The whole course of management of "treatment + maintenance treatment" can continue to relieve symptoms, maintain mucosal healing, and reduce the rate of disease recurrence .
-
Treatment of sewage with lignosulfonate modified flocculant LSDC (2
Time of Update: 2021-11-03
The more filtrate, the lower the moisture content of the sludge cake, and the better the dewatering effect of the flocculant .
Figure 3-31 The change of filtrate volume with timeThrough research, it is found that LSDC flocculant can increase the average sedimentation speed of sludge from 1.
-
The research team invented an oral injection needle that is non-invasive and painless to achieve better efficacy
Time of Update: 2021-09-19
The test results show that for the needle injection depths of 3mm and 4mm, the drug dose is sometimes delivered to the mucosa instead of the submucosa.
-
Blood: Oral ixazomib-lenalidomide-dexamethasone treatment of newly diagnosed multiple myeloma that cannot be transplanted
Time of Update: 2021-08-02
A continuous regimen based on lenalidomide-dexamethasone (Rd) is one of the standard treatments for newly diagnosed multiple myeloma (NDMM) patients who are not eligible for transplantation .
Compared with the placebo-Rd group, the ixazomib-Rd group had a complete response rate (26% vs 14%; odds ratio [OR] 2.
-
NEJM: Involving a quarter of the world's population, the "star drug" Semaglutide can effectively improve the progress of fatty liver
Time of Update: 2021-04-13
This study is a 72- week double-blind phase 2 trial involving patients with NASH and F1 , F2, or F3 liver fibrosis confirmed by biopsy .
. A 72- week double-blind phase 2 trial involving patients with NASH and F1 , F2, or F3 liver fibrosis confirmed by biopsy .
-
Sanofi anti-allergy drug hydrochloric acid fiefina tablets have been approved in China
Time of Update: 2021-03-07
In the U.S., the drug has been approved by the FDA: it can be used not only to alleviate seasonal and perennennia allergic rhinitis-related symptoms in adults and children over 12 years of age, including sneezing, runny nose, tears, itching, red eyes and nasal/tickle/throat itching; according to Sanofi's official website, hydrochloric acid fissolamine inhibits histamine-induced skin spots and flare reactions.
-
Leaf Disk Transformation Using Agrobacterium tumefaciens-Expression of Heterologous Genes in Tobacco
Time of Update: 2021-01-20
The protocol presented here works well in our hands withNicotiana tabacum cultivar “petit havana” mutant SR1 ( 2 ) andAgrobacterium tumefaciens strain LBA4404 ( 3 ) harboring binary vectors conferring kanamycin resistance (100 mg/L).
-
Progress has been made in the study of gene silencing at the National Nano-Center
Time of Update: 2021-01-06
(Source: National Nanoscience Center) Related paper information: chain antisocial nucleic acids and small interference RNA co-assembled to build a gene therapy type nucleic acid nanocomposing structure, targeting tumors to achieve tumor growth inhibition
